TI
Trexquant Investment’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.27M | Sell |
11,936
-44,995
| -79% | -$23.6M | 0.07% | 434 |
|
|
2025
Q1 | $36.1M | Buy |
56,931
+306
| +0.5% | +$194K | 0.42% | 23 |
|
|
2024
Q4 | $40.3M | Buy |
56,625
+42,674
| +306% | +$30.4M | 0.47% | 15 |
|
|
2024
Q3 | $14.7M | Buy |
+13,951
| New | +$14.7M | 0.19% | 148 |
|
|
2024
Q1 | – | Sell |
-5,891
| Closed | -$5.17M | – | 1727 |
|
|
2023
Q4 | $5.17M | Buy |
+5,891
| New | +$5.17M | 0.12% | 241 |
|
|
2022
Q1 | – | Sell |
-2,230
| Closed | -$1.41M | – | 1655 |
|
|
2021
Q4 | $1.41M | Sell |
2,230
-8,625
| -79% | -$5.45M | 0.09% | 293 |
|
|
2021
Q3 | $6.57M | Buy |
+10,855
| New | +$6.57M | 0.52% | 23 |
|
|
2021
Q1 | – | Sell |
-3,717
| Closed | -$1.8M | – | 1404 |
|
|
2020
Q4 | $1.8M | Buy |
+3,717
| New | +$1.8M | 0.19% | 139 |
|
|
2020
Q1 | – | Sell |
-1,980
| Closed | -$743K | – | 1362 |
|
|
2019
Q4 | $743K | Sell |
1,980
-6,722
| -77% | -$2.52M | 0.04% | 440 |
|
|
2019
Q3 | $2.41M | Buy |
8,702
+1,076
| +14% | +$298K | 0.21% | 136 |
|
|
2019
Q2 | $2.39M | Buy |
+7,626
| New | +$2.39M | 0.21% | 147 |
|
|
2018
Q2 | – | Sell |
-4,022
| Closed | -$1.39M | – | 1150 |
|
|
2018
Q1 | $1.39M | Sell |
4,022
-6,253
| -61% | -$2.15M | 0.1% | 329 |
|
|
2017
Q4 | $3.86M | Buy |
+10,275
| New | +$3.86M | 0.42% | 22 |
|
|
2016
Q3 | – | Sell |
-6,000
| Closed | -$2.1M | – | 957 |
|
|
2016
Q2 | $2.1M | Buy |
6,000
+500
| +9% | +$175K | 0.28% | 88 |
|
|
2016
Q1 | $1.98M | Buy |
5,500
+1,000
| +22% | +$360K | 0.23% | 108 |
|
|
2015
Q4 | $2.44M | Buy |
+4,500
| New | +$2.44M | 0.22% | 112 |
|
|
2015
Q2 | – | Sell |
-1,400
| Closed | -$632K | – | 1195 |
|
|
2015
Q1 | $632K | Buy |
+1,400
| New | +$632K | 0.06% | 597 |
|